1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
AxoGen, Inc.

AxoGen, Inc.

AXGN
AxoGen, Inc.US flagNASDAQ Capital Market
39.37
USD
-0.89
- -
2.09BMarket Cap

Total Valuation

AxoGen, Inc. carries a market capitalization of 2.09B, placing it among publicly traded companies globally. Its enterprise value stands at 1.50B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.09B
Enterprise Value1.50B

Share Statistics

AxoGen, Inc. currently has 53.15M shares outstanding.

Shares Outstanding53.15M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 6.65, and the price-to-book ratio stands at -4.85.

PE RatioN/A
PS Ratio6.65
PB Ratio-4.85
P/TBV Ratio6.66
P/FCF Ratio69.07
P/OCF Ratio101.74

Enterprise Valuation

On an enterprise value basis, AxoGen, Inc. trades at an EV/EBITDA multiple of 2,503.90 and an EV/FCF ratio of 50.73. The EV/Sales ratio of 6.31 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 532.96 provides insight into valuation relative to core operating earnings.

EV / Sales6.31
EV / EBITDA2,503.90
EV / EBIT532.96
EV / FCF50.73

Financial Position

AxoGen, Inc. maintains a current ratio of 7.10, meaning it holds 7.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.43, indicating elevated leverage, while an interest coverage ratio of -0.04 demonstrates limited ability to service its debt obligations.

Current Ratio7.10
Quick Ratio4.99
Debt / Equity8.43
Debt / EBITDA-76.74
Interest Coverage-0.04

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-12.95
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-15.48
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.46

Stock Price Statistics

AxoGen, Inc.'s stock has gained approximately 192.49629% over the past 52 weeks. The 50-day moving average sits at 42.04, while the 200-day moving average is 33.22.

Beta (5Y)N/A
52-Week Price Change192.49629%
50-Day Moving Average42.04
200-Day Moving Average33.22
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, AxoGen, Inc. generated 238.11M in revenue and converted that into -31.45M in net income, yielding earnings per share of -0.64. EBITDA reached -269,000.00, while operating income came in at -9.02M.

Revenue238.11M
Gross Profit178.61M
Operating Income-9.02M
Pretax Income-31.45M
Net Income-31.45M
EBITDA-269,000.00
EBIT-9.02M
Earnings Per Share (EPS)-0.64

Balance Sheet

AxoGen, Inc. holds 101.60M in cash and equivalents against 20.64M in total debt, resulting in a net debt position of -82.65M. Total book value stands at -326.01M, with working capital of 158.70M providing operational flexibility.

Cash & Cash Equivalents101.60M
Total Debt20.64M
Net Debt-82.65M
Equity (Book Value)-326.01M
Book Value Per Share-6.82
Working Capital158.70M

Cash Flow

AxoGen, Inc. produced 15.56M in operating cash flow over the past twelve months. After subtracting -7.90M in capital expenditures, free cash flow totaled 7.66M - equivalent to 0.16 per share.

Operating Cash Flow15.56M
Capital Expenditures-7.90M
Free Cash Flow7.66M
FCF Per Share0.16

Margins

AxoGen, Inc. operates with a gross margin of 75.01, reflecting its pricing power and cost economics. The operating margin of -3.79 and net profit margin of -13.21 provide insight into operational efficiency.

Gross Margin75.01
Operating Margin-3.79
Pretax Margin-13.21
Profit Margin-13.21
EBITDA Margin-0.11

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-4.27
FCF Yield1.45

Stock Splits

AxoGen, Inc.'s most recent stock split took place on July 11, 1994 with a 20:21 split ratio.

Last Split Date7/11/1994
Split Ratio20:21

Scores

AxoGen, Inc. posts an Altman Z-Score of 21.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score21.05